VMD
Viemed Healthcare Inc
9.40$
+0.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.7% | 0.0% | +5.9% | +3.4% | +4.4% | +0.6% | +3.7% | +9.6% | +6.2% | -8.2% | +3.5% | |
| – | +7.0% | +0.7% | +16.5% | +6.1% | +10.9% | -7.1% | +12.6% | -9.6% | -3.0% | +2.7% | +8.3% | |
| – | +27.4% | -43.1% | +20.5% | +28.8% | +54.6% | -42.1% | +97.0% | -44.4% | +21.4% | -27.7% | +9.4% | |
| – | +27.4% | -43.1% | +20.5% | +28.8% | +54.6% | -42.1% | +97.0% | -44.4% | +21.4% | -27.7% | +9.4% | |
| – | +2.9% | +32.7% | +12.4% | -1.7% | -7.9% | +7.5% | -0.9% | +10.5% | -12.8% | +21.9% | +3.4% | |
| – | -0.9% | -6.0% | +1.7% | -2.6% | +0.2% | +4.4% | -4.1% | +21.9% | -4.2% | +2.7% | +1.6% | |
| – | +0.2% | +0.0% | +10.8% | +0.0% | +0.0% | +0.0% | +0.0% | +77.2% | +0.8% | +0.0% | +0.0% | |
| – | -17.6% | -5.8% | +70.8% | -3.5% | -3.6% | -3.8% | -4.0% | +72.2% | -4.7% | -5.0% | -5.2% | |
| – | +1.0% | -5.8% | +10.8% | -0.1% | +2.4% | -5.6% | +4.0% | +55.6% | +6.8% | -27.8% | +13.0% | |
| – | +1.8% | -6.2% | +4.5% | +15.8% | +2.4% | -4.9% | +5.0% | +18.6% | -7.1% | -0.9% | +17.7% | |
| – | -16.7% | -25.6% | +8.5% | +0.2% | -21.7% | +4.5% | +30.4% | +56.2% | -15.2% | -9.6% | +2.9% | |
| – | -20.2% | -64.6% | +290.2% | -1.2% | -7.6% | +35.3% | -0.3% | +14.5% | -14.5% | +8.6% | -18.0% | |
| – | -25.9% | -1.6% | +47.6% | -58.1% | -1.7% | -1.6% | -1.8% | +465.2% | -42.3% | -26.2% | -23.5% | |
| – | +4.7% | +2.1% | +2.7% | +4.7% | +5.1% | +2.6% | +3.7% | -4.4% | +5.9% | +1.6% | +0.1% | |
| – | +4.6% | +0.8% | +1.8% | +4.6% | +5.1% | +1.2% | +3.4% | +3.6% | +5.8% | +2.5% | +2.6% | |
| – | -0.1% | +0.5% | -0.1% | +0.6% | +1.8% | +0.3% | -1.3% | -1.4% | -0.8% | +0.8% | +1.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.